Protein Information

ID 1735
Name peroxisome proliferator activated receptor
Synonyms NR1C1; PPAR; PPAR alpha; PPARA; PPARalpha; Peroxisome proliferator activated receptor; Peroxisome proliferator activated receptor alpha; hPPAR…

Compound Information

ID 954
Name SMA
CAS sodium 2-chloroacetate

Reference

PubMed Abstract RScore(About this table)
20212046 Zhang L, Xie P, Wang J, Yang Q, Fang C, Zhou S, Li J: Impaired peroxisome proliferator-activated receptor-{gamma} contributes to phenotypic modulation of vascular smooth muscle cells during hypertension. J Biol Chem. 2010 Mar 8.
The phenotypic modulation of vascular smooth muscle cells (VSMCs) plays pivotal role in hypertension-induced vascular changes including vascular remodeling. The precise mechanisms underlying VSMC phenotypic modulation remain elusive. Here we test the role of peroxisome proliferator-activated receptor (PPAR)-gamma in the VSMC phenotypic modulation during hypertension. Both spontaneously hypertensive rat (SHR) aortas and SHR-derived VSMCs exhibited reduced PPAR-gamma expression and excessive VSMC phenotypic modulation identified by reduced contractile proteins, alpha-smooth muscle actin (alpha-SMA) and smooth muscle 22alpha (SM22alpha), and enhanced proliferation and migration. PPAR-gamma overexpression rescued the expression of alpha-SMA and SM22alpha, and inhibited the proliferation and migration in SHR-derived VSMCs. In contrast, PPAR-gamma silencing exerted the opposite effect. Activating PPAR-gamma using rosiglitazone in vivo upregulated aortic alpha-SMA and SM22alpha expression and attenuated aortic remodeling in SHRs. Increased activation of phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT) signaling was observed in SHR-derived VSMCs. PI3K inhibitor LY294002 rescued the impaired expression of contractile proteins, and inhibited proliferation and migration in VSMCs from SHRs, while constitutively active PI3K mutant had the opposite effect. Overexpression or silencing of PPAR-gamma respectively inhibited or excited PI3K/Akt activity. LY294002 counteracted PPAR-gamma silencing induced proliferation and migration in SHR-derived VSMCs, while active PI3K mutant had the opposite effect. In contrast, reduced proliferation and migration by PPAR-gamma overexpression were reversed by active PI3K mutant, and further inhibited by LY294002. We conclude that PPAR-gamma inhibit VSMC phenotypic modulation through inhibiting PI3K/Akt signaling. Impaired PPAR-gamma expression is responsible for VSMC phenotypic modulation during hypertension. These findings highlight an attractive therapeutic target for hypertension-related vascular disorders.
1(0,0,0,1)